Caris Life Sciences
Last verified 2026-05-18. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.2Battributed |
|---|---|
| Latest round | series-d+, $168.0M, 2025-04-01attributed |
| Founded | 2018 |
| Headquarters | Irving, USA |
| Industry | bio |
| Stage | series-b+ |
| Website | carislifesciences.com |
Caris MI Profile performs whole-exome and whole-transcriptome sequencing on tumor tissue, analyzing 23,000+ genes alongside protein expression data to build a molecular blueprint of a patient's cancer. It serves oncologists and cancer patients seeking personalized treatment guidance. The test combines DNA, RNA, and protein analysis with AI-predictive algorithms in a single tissue-based assay — a multi-omic profile most competitors split across separate workflows.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-04-01 | series-d+ | $168.0M | undisclosed |
Detected tech stack
Nginx, WordPress 6.9.4, Yoast SEO 27.6, Google Tag Manager, WordPress Block Editor, WordPress Site Editor, WordPress VIP, PHP, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series D+, $168.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $1.2B | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | carislifesciences.com, read 2026-05-18 |
| Description | self-reported | carislifesciences.com, read 2026-05-18 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.